* Precigen Inc PGEN.OQ reported a quarterly adjusted loss
of 13
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -11
cents. The mean expectation of five analysts for the quarter
was for a loss of 8 cents per share. Wall Street expected
results to range from -8 cents to -7 cents per share.
* Revenue fell 30.3% to $1.23 million from a year ago;
analysts
expected $1.70 million.
* Precigen Inc's reported EPS for the quarter was a loss
of 13
cents.
* The company reported a quarterly loss of $33.06 million.
* Precigen Inc shares had risen by 3.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Precigen
Inc is
$7.00
This summary was machine generated from LSEG data March 19 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.08 -0.13 Missed
Sep. 30 2023 -0.08 -0.08 Met
Jun. 30 2023 -0.10 -0.08 Beat
Mar. 31 2023 -0.09 -0.10 Missed